• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1感染的病毒血症自发控制者的人口统计学和自然史。

Demographics and natural history of HIV-1-infected spontaneous controllers of viremia.

作者信息

Yang Otto O, Cumberland William G, Escobar Robert, Liao Diana, Chew Kara W

机构信息

aAIDS Healthcare Foundation bDavid Geffen School of Medicine cDepartment of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California, USA.

出版信息

AIDS. 2017 May 15;31(8):1091-1098. doi: 10.1097/QAD.0000000000001443.

DOI:10.1097/QAD.0000000000001443
PMID:28301422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5657480/
Abstract

OBJECTIVES

HIV-1-infected persons spontaneously controlling viremia without treatment (SCV) are rare. Sex and race effects on prevalence and outcome are poorly defined, and it is unclear whether SCV qualitatively or quantitatively differs from typical infection. These issues are examined in this article.

DESIGN

Medical records of 46 524 persons receiving outpatient care for HIV-1 infection were reviewed. Of these, 29 811 had adequate viremia testing for SCV screening.

METHODS

SCV was defined as at least three consecutive plasma viremia measurements <50 RNA copies/ml spanning at least 1 year without treatment. SCV loss was defined as at least three consecutive viremia measurements ≥50 RNA copies/ml or one ≥1000 RNA copies/ml. Demographics of persons with SCV were compared with the total population. Viremia and blood CD4 T-cell levels during SCV were compared between demographic subgroups and persons who maintained or lost SCV during observation.

RESULTS

In total, 53 persons (0.18%) met SCV criteria. Prevalence was higher for women versus men and blacks versus whites; these appeared independent. Loss of SCV was observed at 1.22% per year, and significantly associated with viremia 'blips'. Blip magnitudes fit log-normal distributions with means below 50 RNA copies/ml.

CONCLUSION

Our novel observation of higher SCV prevalence in women and blacks is consistent with prior studies of typical chronic infection. Viremia blips correspond to greater risk of loss of SCV, likely reflecting higher set-point viremia under the limit of detection. Our findings suggest that SCV represents an extreme along a continuum of HIV-1 infection, and not qualitative difference.

摘要

目的

未经治疗而能自发控制病毒血症的HIV-1感染者(SCV)很罕见。性别和种族对其患病率及转归的影响尚不明确,且不清楚SCV在性质或数量上是否与典型感染有所不同。本文对这些问题进行了研究。

设计

回顾了46524例接受HIV-1感染门诊治疗患者的病历。其中,29811例有足够的病毒血症检测结果用于SCV筛查。

方法

SCV定义为至少连续三次血浆病毒血症测量值<50 RNA拷贝/ml,持续至少1年且未经治疗。SCV丧失定义为至少连续三次病毒血症测量值≥50 RNA拷贝/ml或一次≥1000 RNA拷贝/ml。将SCV患者的人口统计学特征与总体人群进行比较。比较了不同人口统计学亚组以及观察期间维持或丧失SCV的患者在SCV期间的病毒血症和血液CD4 T细胞水平。

结果

共有53例患者(0.18%)符合SCV标准。女性患病率高于男性,黑人高于白人;这些差异似乎具有独立性。每年观察到1.22%的患者丧失SCV,且与病毒血症“波动”显著相关。波动幅度符合均值低于50 RNA拷贝/ml的对数正态分布。

结论

我们关于女性和黑人中SCV患病率较高的新观察结果与先前关于典型慢性感染的研究一致。病毒血症波动与丧失SCV的风险增加相关,这可能反映了在检测限以下更高的病毒血症设定点。我们的研究结果表明,SCV代表了HIV-1感染连续谱中的一个极端情况,而非性质上的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/6b1d5bc3007c/nihms913922f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/baf0701a0dc0/nihms913922f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/7b4b105f602a/nihms913922f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/3d163422aeee/nihms913922f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/596a7ed6dc64/nihms913922f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/6b1d5bc3007c/nihms913922f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/baf0701a0dc0/nihms913922f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/7b4b105f602a/nihms913922f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/3d163422aeee/nihms913922f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/596a7ed6dc64/nihms913922f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/5657480/6b1d5bc3007c/nihms913922f5.jpg

相似文献

1
Demographics and natural history of HIV-1-infected spontaneous controllers of viremia.HIV-1感染的病毒血症自发控制者的人口统计学和自然史。
AIDS. 2017 May 15;31(8):1091-1098. doi: 10.1097/QAD.0000000000001443.
2
Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.接受高效抗逆转录病毒治疗(HAART)的患者中的间歇性HIV-1病毒血症(病毒载量波动)和耐药性。
JAMA. 2005 Feb 16;293(7):817-29. doi: 10.1001/jama.293.7.817.
3
Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infection.在慢性与急性及早期1型人类免疫缺陷病毒感染期间开始接受治疗的患者中,高效抗逆转录病毒治疗期间间歇性病毒血症的动态变化。
J Virol. 2004 Oct;78(19):10566-73. doi: 10.1128/JVI.78.19.10566-10573.2004.
4
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.在未接受抗逆转录病毒治疗的情况下控制人类免疫缺陷病毒的个体中存在持续性低水平病毒血症的证据。
J Virol. 2009 Jan;83(1):329-35. doi: 10.1128/JVI.01763-08. Epub 2008 Oct 22.
5
Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?在病毒学得到持续抑制的HIV感染患者中,病毒载量波动和低水平病毒血症发作对抗逆转录病毒治疗有何影响?
J Antimicrob Chemother. 2016 Apr;71(4):1051-5. doi: 10.1093/jac/dkv433. Epub 2015 Dec 24.
6
Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia.尽管血浆病毒载量稳定,但在未经治疗的感染无症状期,细胞内 HIV-1 载量仍持续增加。
AIDS. 2010 Jul 17;24(11):1641-9. doi: 10.1097/QAD.0b013e32833b3171.
7
HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients.HIV-1极低水平病毒血症与高效抗逆转录病毒治疗患者的病毒学失败相关。
AIDS Res Hum Retroviruses. 2015 Oct;31(10):999-1008. doi: 10.1089/AID.2015.0102. Epub 2015 Aug 6.
8
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.耐药基因型对接受大量抗逆转录病毒治疗的HIV感染患者CD4+细胞计数和血浆病毒血症的影响。
J Med Virol. 2005 Sep;77(1):23-8. doi: 10.1002/jmv.20395.
9
HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).垂直感染的无症状或轻症未治疗儿童的HIV-1病毒载量和CD4细胞计数。欧洲儿科艾滋病治疗网络(PENTA)。
AIDS. 1998 Mar 5;12(4):F1-8.
10
Brief Report: Prevalence of Posttreatment Controller Phenotype Is Rare in HIV-Infected Persons After Stopping Antiretroviral Therapy.简要报告:停止抗逆转录病毒治疗后,HIV感染者中治疗后控制者表型的患病率很低。
J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):364-369. doi: 10.1097/QAI.0000000000001393.

引用本文的文献

1
Human models that inform antiretroviral therapy-free remission with perinatally acquired HIV infection.为围产期获得性HIV感染的无抗逆转录病毒治疗缓解提供信息的人体模型。
Curr Opin HIV AIDS. 2025 May 1;20(3):249-256. doi: 10.1097/COH.0000000000000918. Epub 2025 Mar 19.
2
Viremic non-progression in HIV/SIV infection: A tied game between virus and host.HIV/SIV感染中的病毒血症无进展:病毒与宿主之间的平局。
Cell Rep Med. 2025 Jan 21;6(1):101921. doi: 10.1016/j.xcrm.2024.101921.
3
The impact of sex on HIV immunopathogenesis and therapeutic interventions.

本文引用的文献

1
Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.针对多个保守表位的细胞毒性T细胞对HIV-1的临床控制
J Virol. 2015 May;89(10):5330-9. doi: 10.1128/JVI.00020-15. Epub 2015 Mar 4.
2
[A follow-up study of HIV long-term non-progress populations in Henan province].[河南省HIV长期不进展人群的随访研究]
Zhonghua Yu Fang Yi Xue Za Zhi. 2014 Aug;48(8):684-7.
3
An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration.一项在大型血清转化者队列合作中对HIV精英控制者定义的评估。
性对 HIV 免疫发病机制和治疗干预的影响。
J Clin Invest. 2024 Sep 17;134(18):e180075. doi: 10.1172/JCI180075.
4
Modelling HIV-1 control and remission.模拟HIV-1的控制与缓解
NPJ Syst Biol Appl. 2024 Aug 8;10(1):84. doi: 10.1038/s41540-024-00407-8.
5
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.尽管在 HIV 宫内传播后男性儿童未坚持抗逆转录病毒治疗,但仍持续出现病毒血症。
Nat Med. 2024 Oct;30(10):2796-2804. doi: 10.1038/s41591-024-03105-4. Epub 2024 Jun 6.
6
Pregnancy Management in HIV Viral Controllers: Twenty Years of Experience.HIV病毒控制者的妊娠管理:二十年经验
Pathogens. 2024 Apr 10;13(4):308. doi: 10.3390/pathogens13040308.
7
IL-15-dependent immune crosstalk between natural killer cells and dendritic cells in HIV-1 elite controllers.HIV-1 精英控制者中自然杀伤细胞和树突状细胞之间依赖 IL-15 的免疫串扰。
Cell Rep. 2023 Dec 26;42(12):113530. doi: 10.1016/j.celrep.2023.113530. Epub 2023 Dec 3.
8
Sex Differences in HIV Infection.HIV 感染中的性别差异。
Curr Top Microbiol Immunol. 2023;441:61-73. doi: 10.1007/978-3-031-35139-6_3.
9
HIV infection.艾滋病毒感染。
Nat Rev Dis Primers. 2023 Aug 17;9(1):42. doi: 10.1038/s41572-023-00452-3.
10
The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells.潜伏逆转剂 HODHBt 与 IL-15 协同作用,增强 HIV 特异性 T 细胞的细胞毒性功能。
JCI Insight. 2023 Sep 22;8(18):e169028. doi: 10.1172/jci.insight.169028.
PLoS One. 2014 Jan 28;9(1):e86719. doi: 10.1371/journal.pone.0086719. eCollection 2014.
4
Slow progressor of human immunodeficiency virus: 20 years follow-up of a case from North India.人类免疫缺陷病毒缓慢进展者:来自印度北部一例病例的20年随访
Indian J Med Microbiol. 2014 Jan-Mar;32(1):75-6. doi: 10.4103/0255-0857.124325.
5
Unravelling the mechanisms of durable control of HIV-1.解析 HIV-1 持久控制的机制。
Nat Rev Immunol. 2013 Jul;13(7):487-98. doi: 10.1038/nri3478.
6
Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.宿主因素决定了在两对 HIV-1 控制者/慢性进展者传播者中对病毒复制的控制。
Nat Commun. 2012 Mar 6;3:716. doi: 10.1038/ncomms1697.
7
Epidemiology and clinical characteristics of elite controllers.精英控制者的流行病学和临床特征。
Curr Opin HIV AIDS. 2011 May;6(3):163-8. doi: 10.1097/COH.0b013e328344f35e.
8
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection.性别、种族和地理位置影响原发性 HIV-1 感染后的临床结局。
J Infect Dis. 2011 Feb 15;203(4):442-51. doi: 10.1093/infdis/jiq085. Epub 2011 Jan 18.
9
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.HIV-1 控制的主要遗传决定因素影响 HLA Ⅰ类肽的呈递。
Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4.
10
Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.美国国防部HIV自然史研究中精英控制者、病毒血症控制者和长期不进展者的临床结局。
J Infect Dis. 2009 Dec 1;200(11):1714-23. doi: 10.1086/646609.